The Analytics Powering RNA Drug Development
By Marwan Alsarraj
August 21, 2025
RNA therapeutics are advancing rapidly, but their clinical success depends on the availability of precise, reliable analytical methods.
11 min read
False
By Marwan Alsarraj
August 21, 2025
RNA therapeutics are advancing rapidly, but their clinical success depends on the availability of precise, reliable analytical methods.
11 min read
August 21, 2025
We find out why bispecific antibodies are helping to build momentum against myeloma.
4 min read
August 19, 2025
Elsevier’s Mirit Eldor discusses a new AI platform for biomedical research and the importance of preventing hallucinations.
5 min read
By Corey Ohnmacht, Suzanne Jansen
August 15, 2025
Looking at the importance of stability programs in early clinical drug product development.
4 min read
By Heather Purvis
August 12, 2025
Academic medical centers are racing to adapt as political turnover and funding uncertainty threaten the future of cell and gene therapy research.
5 min read
August 12, 2025
As obefazimod reports positive phase III results, we discuss the strategic decisions that fueled rapid trial enrollment and how the groundwork is being laid for a potential market launch.
5 min read
By George Magrath, Ram Yalamanchili
July 21, 2025
A sponsor's perspective on efficiency and scalability gains from using AI.
9 min read
By Rob Coker
July 18, 2025
Researchers at Roche-Genentech have found a way to help more antisense oligonucleotides reach their targets – by slowing things down inside cells.
3 min read
By Rob Coker
July 16, 2025
An Oxford University-led study has found that the Parkinson’s drug pramipexole might be just the dopamine boost that treatment-resistant depression has been waiting for.
3 min read
July 15, 2025
We interview Pfizer and Lokavant about their partnership and why AI is the future of clinical trials.
9 min read
False
False
False